These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. "How to manage loss of response to anti-TNF in Crohn's disease? ". Reinisch W Curr Drug Targets; 2010 Feb; 11(2):152-5. PubMed ID: 20210764 [TBL] [Abstract][Full Text] [Related]
14. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature. Jürgens M; Brand S; Filik L; Hübener C; Hasbargen U; Beigel F; Tillack C; Göke B; Ochsenkühn T; Seiderer J Inflamm Bowel Dis; 2010 Oct; 16(10):1634-6. PubMed ID: 20027647 [No Abstract] [Full Text] [Related]
15. [Oligosymptomatic alimentary tract perforation in course of Crohn's disease in patient treated with anti-TNF alfa antibodies]. Jałocha Ł; Wojtuń S; Wojtkowiak M; Błaszak A; Dyrla P; Gil J Pol Merkur Lekarski; 2009 May; 26(155):491-2. PubMed ID: 19606707 [TBL] [Abstract][Full Text] [Related]
16. Adalimumab for cutaneous metastatic Crohn's disease. Cury DB; Moss AC; Elias G; Nakao A Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388 [No Abstract] [Full Text] [Related]
18. Review article: loss of response to anti-TNF treatments in Crohn's disease. Ben-Horin S; Chowers Y Aliment Pharmacol Ther; 2011 May; 33(9):987-95. PubMed ID: 21366636 [TBL] [Abstract][Full Text] [Related]
19. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series. Absah I; Faubion WA Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Crohn's disease at the turn of the century. Bickston SJ; Cominelli F N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110 [No Abstract] [Full Text] [Related] [Next] [New Search]